SDGR

#2163
Schrodinger, Inc. Common Stock
12.06
-2.35%
Sector:
Base:
Profit Currency:
Daily Range
12.06
12.06
Year Range
11.11
27.63
Daily Change
-2.35%
Monthly Change
-19.11%
6 month change
-39.12%
Year Change
-44.68%
Previous Close
12.35
Open
12.06
Bid
Ask
Low
12.06
High
12.06
Volume
119
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
  • Market Capitalization 885.73 M
  • Employee 787
  • Founded 1990
  • CEO Ramy Farid
  • Website www.schrodinger.com
  • Headquarter Delaware, United States
  • FIGI BBG000T88BN2
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-12.68
Price to sales ratio
5.13
Dividends per share
—
Dividend yield %
—

Schrodinger Inc

Schrödinger, Inc. is an international scientific software and biotechnology company that specializes in developing computational tools and software for drug discovery and materials science. Schrödinger's software is used by pharmaceutical companies, biotech, tech, chemicals, energy, aerospace firms, and academic researchers to simulate and model the behavior of molecules at the atomic level. This accelerates the design and develops new drugs and materials more efficiently, reducing the time and cost of bringing them to market. Schrödinger's software tools include molecular dynamics simulations, free energy calculations, quantum mechanics calculations, and virtual screening tools. The company also offers consulting services and collaborates with partners in the industry to advance the field of computational chemistry and drug discovery.

News